Poor prognosis associated with gain of chromosome 1Q21 in multiple myeloma may be overcome by treatment with a bortezomib combination

被引:0
|
作者
Sagaster, V.
Odelga, V.
Kaufmann, H.
Ackermann, J.
Galhuber, M.
Zojer, N.
Ludwig, H.
Wieser, R.
Zielinski, C.
Drach, J.
机构
[1] Med Univ Vienna, Vienna, Austria
[2] Wilhelminenspital Stadt Wien, Dept Med 1, Vienna, Austria
来源
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
0405
引用
收藏
页码:149 / 149
页数:1
相关论文
共 50 条
  • [41] Gain(1)(q21) Defines Group of Newly Diagnosed Multiple Myeloma Patients with Poor Prognosis.
    Nemec, Pavel
    Greslikova, Henrieta
    Zaoralova, Romana
    Smetana, Jan
    Filkova, Hana
    Dementyeva, Elena
    Kupska, Renata
    Berankova, Kristina
    Mikulasova, Aneta
    Pour, Ludek
    Zahradova, Lenka
    Kuglik, Petr
    Hajek, Roman
    BLOOD, 2009, 114 (22) : 1102 - 1103
  • [42] Clinical and biological characteristics of multiple myeloma with 1q21 amplification
    钟仕贞
    China Medical Abstracts (Internal Medicine), 2016, 33 (02) : 52 - 52
  • [43] Impact of cytogenetics in patients with relapsed or refractory multiple myeloma treated with bortezomib: Adverse effect of 1q21 gains
    Chang, Hong
    Trieu, Young
    Qi, Xiaoying
    Jiang, Nan N.
    Xu, Wei
    Reece, Donna
    LEUKEMIA RESEARCH, 2011, 35 (01) : 95 - 98
  • [44] The Independent Adverse Prognostic Significance of 1q21 Gain/Amplification in Newly Diagnosed Multiple Myeloma Patients
    You, Hongying
    Jin, Song
    Wu, Chunxiao
    Wang, Qingqing
    Yan, Shuang
    Zhai, Yingying
    Yao, Weiqin
    Shi, Xiaolan
    Shang, Jingjing
    Yan, Lingzhi
    Yao, Ying
    Wang, Jing
    Wang, Panfeng
    Pan, Jinlan
    Wu, Depei
    Fu, Chengcheng
    BLOOD, 2022, 140 : 10056 - 10057
  • [45] The independent adverse prognostic significance of 1q21 gain/amplification in newly diagnosed multiple myeloma patients
    You, Hongying
    Jin, Song
    Wu, Chunxiao
    Wang, Qingqing
    Yan, Shuang
    Yao, Weiqin
    Shi, Xiaolan
    Shang, Jingjing
    Yan, Lingzhi
    Yao, Ying
    Wang, Jing
    Wang, Panfeng
    Pan, Jinlan
    Wu, Depei
    Fu, Chengcheng
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [46] Predictive value of 1q21 gain in multiple myeloma is strongly dependent on concurrent cytogenetic abnormalities and first-line treatment
    Minguela, Alfredo
    Vasco-Mogorron, Maria A.
    Campillo, Jose A.
    Cabanas, Valentin
    Remigia, Maria J.
    Berenguer, Mercedes
    Garcia-Garay, Maria C.
    Blanquer, Miguel
    Cava, Catalina
    Galian, Jose Antonio
    Gimeno, Lourdes
    Soto-Ramirez, Maria F.
    Martinez-Hernandez, Maria D.
    de la Rubia, Javier
    Teruel, Ana, I
    Muro, Manuel
    Periago, Adela
    AMERICAN JOURNAL OF CANCER RESEARCH, 2021, 11 (09): : 4438 - +
  • [47] PREDICTIVE VALUE OF 1Q21 GAIN IN MULTIPLE MYELOMA DEPENDS LARGELY ON CONCURRENT CYTOGENETIC ABNORMALITIES AND FIRST-LINE TREATMENT
    Maria, Martinez-Hernandez D.
    Periago, A.
    Maria, Vasco-Mogorron
    Jose, Campillo A.
    Valentin, Cabanas
    Maria, Remigia J.
    Mercedes, Berenguer
    Maria, Garcia-Garay C.
    Miguel, Blanquer
    Catalina, Cava
    Jose, Galian A.
    Lourdes, Gimeno
    Maria, Soto-Ramirez D.
    Javier, De la Rubia
    Ana, Teruel, I
    Manuel, Muro
    Alfredo, Minguela
    HAEMATOLOGICA, 2021, 106 (10) : 180 - 180
  • [48] ILF2 IS UPREGULATED BY 1Q21 AMPLIFICATION IN MULTIPLE MYELOMA
    不详
    CANCER DISCOVERY, 2017, 7 (08) : 795 - 795
  • [49] Hepatitis B virus infection and 1q21 amplification in multiple myeloma
    Guo, Dan
    Xu, Peipei
    Guan, Chaoyang
    Xu, Yong
    Yang, Yonggong
    Xu, Jingyan
    Zhou, Rongfu
    Chen, Bing
    ONCOLOGY LETTERS, 2019, 18 (06) : 6196 - 6206
  • [50] Chromosome 1q12 Instability Drives Both 1q21 Amplification and Arm-Length Deletions in Multiple Myeloma
    Sawyer, Jeffery R.
    Tian, Erming
    Walker, Brian A.
    Swanson, Charles M.
    Lukacs, Janet L.
    Sammartino, Gael M.
    Bailey, Clyde
    Thanendrarajan, Sharmilan
    Schinke, Carolina D.
    Zangari, Maurizio
    van Rhee, Frits
    Davies, Faith E.
    Morgan, Gareth J.
    BLOOD, 2017, 130